Dr David Vidal

Biography

 He received his Ph.D. in Organic Chemistry from the University of Barcelona in 2006. Under the supervision of Prof. Miquel Pons, he specialized in the design and development of modeling techniques and algorithms for drug discovery. In 2007, after a postdoctoral stage at Origenis GmbH (Munich, Germany), he returned to Barcelona to join the scientific team of Chemotargets where, in the course of nine years, he contributed to the development of their discovery platform and, in collaboration with different pharmaceutical and biotechnology companies, participated in different drug discovery projects mainly focused on the early identification and optimization of new molecular entities. At the end of 2016, he joined Mind the Byte as Head of In Silico Pharmacology being appointed R&D director in 2017, with the global objective of designing, developing and consolidating company's drug discovery SaaS platform aimed at the modeling and simulation of preclinical and clinical data.

Research Interest

 Pharma